These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 17079208)

  • 1. Who's in the business of saving lives?
    Lee Chang P
    J Med Philos; 2006 Oct; 31(5):465-82. PubMed ID: 17079208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developing drugs for the developing world: an economic, legal, moral, and political dilemma.
    Resnik DB
    Dev World Bioeth; 2001 May; 1(1):11-32. PubMed ID: 12870505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An ethical argument in support of interactions between developing world countries and pharmaceutical/biotechnology companies involved in oncology drug development.
    Markman M
    Cancer; 2008 May; 112(9):1871-3. PubMed ID: 18318430
    [No Abstract]   [Full Text] [Related]  

  • 4. Some questions about the moral responsibilities of drug companies in developing countries.
    Brock DW
    Dev World Bioeth; 2001 May; 1(1):33-7. PubMed ID: 12870506
    [No Abstract]   [Full Text] [Related]  

  • 5. Introduction: ethical responsibilities regarding drugs, patents, and health.
    Ryan MP
    Bus Ethics Q; 2005 Oct; 15(4):543-7. PubMed ID: 16358441
    [No Abstract]   [Full Text] [Related]  

  • 6. Priceless goods: how should life-saving drugs be priced?
    Maitland I
    Bus Ethics Q; 2002 Oct; 12(4):451-80. PubMed ID: 12708456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxymoron no more: the potential of nonprofit drug companies to deliver on the promise of medicines for the developing world.
    Hale VG; Woo K; Lipton HL
    Health Aff (Millwood); 2005; 24(4):1057-63. PubMed ID: 16012146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The corporate social responsibility of the pharmaceutical industry: idealism without illusion and realism without resignation.
    Leisinger KM
    Bus Ethics Q; 2005 Oct; 15(4):577-94. PubMed ID: 16358443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Social responsibility and global pharmaceutical companies.
    Daniels N
    Dev World Bioeth; 2001 May; 1(1):38-41. PubMed ID: 12870507
    [No Abstract]   [Full Text] [Related]  

  • 10. [AIDS and social justice: pharmaceutical industry and economics].
    López Guzmán J
    Cuad Bioet; 2008; 19(67):563-74. PubMed ID: 19166259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human rights responsibilities of pharmaceutical companies in relation to access to medicines.
    Lee JY; Hunt P
    J Law Med Ethics; 2012; 40(2):220-33. PubMed ID: 22789042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intellectual property and pharmaceutical drugs: an ethical analysis.
    De George RT
    Bus Ethics Q; 2005 Oct; 15(4):549-75. PubMed ID: 16358442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. When medicine becomes a disease.
    Arabia; 1986 Mar; 5(55):32-6. PubMed ID: 12340711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Access to life-saving medicines and intellectual property rights: an ethical assessment.
    Schroeder D; Singer P
    Camb Q Healthc Ethics; 2011 Apr; 20(2):279-89. PubMed ID: 21435303
    [No Abstract]   [Full Text] [Related]  

  • 15. [Global health--the ethical responsibility of the pharmaceutical industry].
    Lassen LC; Thomsen MK
    Ugeskr Laeger; 2006 Sep; 168(36):2994-5. PubMed ID: 16999884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Private-sector research ethics: marketing or good conflicts management? The 2005 John J. Conley Lecture on Medical Ethics.
    Dresser R
    Theor Med Bioeth; 2006; 27(2):115-39. PubMed ID: 16699963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GATT and the gap: how to save lives.
    James JS
    AIDS Treat News; 1998 Nov; (No 307):1, 3-6. PubMed ID: 11366123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moral responsibility and respect for autonomy: meeting the communitarian challenge.
    Guathier CC
    Kennedy Inst Ethics J; 2000 Dec; 10(4):337-52. PubMed ID: 11702770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. International pharmaceutical social risk regulation: An ethical perspective.
    Gordon C
    Acta Pharm; 2011 Mar; 61(1):15-23. PubMed ID: 21406340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Social Responsibilities of the Global Pharmaceutical Companies: Towards an Ethical Health Care Paradigm.
    Kanwar AVS; Rahim MM
    J Law Med; 2019 Jul; 26(4):750-763. PubMed ID: 31682355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.